We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Taro Shareholders Defend Securities Fraud Complaint

Law360 (July 16, 2007, 12:00 AM EDT) -- Shareholders of Taro Pharmaceutical Industries Ltd. have urged a court to ignore the drug company’s motion to toss a securities fraud class action, saying its complaint detailed a fraud that “emanated from the core of Taro’s business.”

A group of pension funds who were appointed lead plaintiffs in the consolidated case filed papers to the Manhattan district court Friday calling for Taro’s motion to be denied “in its entirety.”

The pension funds filed their amended complaint in April against the pharmaceutical company and four former executives,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.